Medigen Biotechnology (ROCO:3176) Interest Expense : NT$-57 Mil (TTM As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Medigen Biotechnology Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Medigen Biotechnology's interest expense for the three months ended in Mar. 2024 was NT$ -14 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was NT$-57 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Medigen Biotechnology's Operating Income for the three months ended in Mar. 2024 was NT$ -138 Mil. Medigen Biotechnology's Interest Expense for the three months ended in Mar. 2024 was NT$ -14 Mil. Medigen Biotechnology did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Medigen Biotechnology Interest Expense Historical Data

The historical data trend for Medigen Biotechnology's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medigen Biotechnology Interest Expense Chart

Medigen Biotechnology Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-31.60

-31.88

-19.07

-39.45

-55.86

Medigen Biotechnology Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-13.53	-13.92	-14.37	-14.04	-14.38

Medigen Biotechnology Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-57 Mil.

Medigen Biotechnology (ROCO:3176) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Medigen Biotechnology's Interest Expense for the three months ended in Mar. 2024 was NT$-14 Mil. Its Operating Income for the three months ended in Mar. 2024 was NT$-138 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was NT$710 Mil.

Medigen Biotechnology's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Medigen Biotechnology did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Medigen Biotechnology (ROCO:3176) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medigen Biotechnology Corp (ROCO:3176) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Yuancyu Street, 14F, Building No.3,, Nangang District, Taipei, TWN, 11560

Website

https://www.medigen.com.tw

Medigen Biotechnology Corp is a biopharmaceutical company primarily engaged in new drug development, drug discovery, molecular diagnostics, vaccine, and generic drugs. The new drug development business focuses mainly on the clinical stage of drug development and includes PI-88 MUPAFOSTAT for the treatment of liver cancer and OBP-301 treatment using adenovirus targeted to cancer cells only. Drug discovery includes the development of human-native mAbs for therapeutic applications related to infectious diseases. Generic drugs include pharmaceuticals for infectious diseases (antibiotics), contraceptives, nutrition milk powder, vitamin C tablets, dermatologic agents, and eye care products.

Medigen Biotechnology (ROCO:3176) Headlines

No Headlines